SCHEMBL21865765

SCHEMBL21865765

Cc1cc(C(F)(F)F)cc(N)c1C=N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 2/20 0.38
ALDH1A1 P00352 4/20 0.36
L3MBTL1 Q9Y468 4/20 0.36
RAB9A P51151 1/20 0.36
MAPT P10636 3/20 0.33
KDM4E B2RXH2 2/20 0.33
PKM P14618 1/20 0.33
IKBKB O14920 1/20 0.33
CFTR P13569 1/20 0.33
RAPGEF4 Q8WZA2 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
LMNA P02545 1/20 0.33
ATM Q13315 1/20 0.33
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
NR2E1 Q9Y466 1/20 0.31
MEN1 O00255 1/20 0.31
GAA P10253 1/20 0.31
GFER P55789 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19249228 0.88 PTPN5 (0.42) PTPN5ALDH1A1L3MBTL1RAB9AMAPT
SCHEMBL21865966 0.73 PTPN5 (0.44) PTPN5ALDH1A1L3MBTL1RAB9AMAPT
SCHEMBL29545905 0.73 ALDH1A1 (0.50) PTPN5ALDH1A1L3MBTL1RAB9AMAPT
SCHEMBL12329602 0.73 ALDH1A1 (0.50) PTPN5ALDH1A1L3MBTL1RAB9AMAPT
SCHEMBL18664288 0.72 CYP3A4 (0.38) ALDH1A1MAPTKDM4EPKMHSD17B10
SCHEMBL13871750 0.72 PTPN5 (0.47) PTPN5ALDH1A1L3MBTL1RAB9AMAPT
Ammonia Solution, Strong SCHEMBL27470283 0.71 PTPN5 (0.42) PTPN5ALDH1A1L3MBTL1RAB9AMAPT
SCHEMBL26806644 0.71 PTPN5 (0.42) PTPN5ALDH1A1L3MBTL1RAB9AMAPT
SCHEMBL9610071 0.69 RAPGEF4 (0.42) PTPN5ALDH1A1L3MBTL1RAB9AMAPT
SCHEMBL18299676 0.69 PTPN5 (0.41) PTPN5ALDH1A1L3MBTL1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3636643-A1 NUCLEAR RECEPTOR MODULATORS (ROR) FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES AbbVie Inc. (US) 2020-04-15 EP disclosed